Andlauer Healthcare Group (TSE:AND) Rating Lowered to Hold at Scotiabank

Scotiabank downgraded shares of Andlauer Healthcare Group (TSE:AND) from a strong-buy rating to a hold rating in a report published on Friday, Zacks.com reports.

Other equities research analysts also recently issued reports about the company. Royal Bank of Canada decreased their price objective on Andlauer Healthcare Group from C$43.00 to C$41.00 and set a sector perform rating for the company in a report on Monday, May 6th. CIBC reduced their price objective on Andlauer Healthcare Group from C$52.00 to C$50.00 and set an outperform rating for the company in a research note on Monday, May 6th. TD Securities lowered their target price on Andlauer Healthcare Group from C$54.00 to C$52.00 and set a buy rating on the stock in a research note on Monday, May 6th. National Bankshares upped their price target on Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the stock a sector perform rating in a research note on Thursday, March 7th. Finally, Eight Capital decreased their price target on Andlauer Healthcare Group from C$62.00 to C$58.00 and set a buy rating for the company in a report on Thursday, March 7th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Andlauer Healthcare Group has a consensus rating of Moderate Buy and a consensus price target of C$49.43.

Andlauer Healthcare Group Trading Down 0.6 %

Shares of Andlauer Healthcare Group stock opened at C$38.66 on Friday. The company has a current ratio of 1.94, a quick ratio of 1.66 and a debt-to-equity ratio of 26.06. The company has a fifty day simple moving average of C$40.08 and a 200-day simple moving average of C$40.51. The stock has a market cap of C$753.10 million, a price-to-earnings ratio of 25.60 and a beta of 0.69. Andlauer Healthcare Group has a 12-month low of C$36.43 and a 12-month high of C$45.67.

Andlauer Healthcare Group (TSE:AND) last announced its quarterly earnings results on Thursday, May 2nd. The company reported C$0.35 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.53 by C($0.18). The company had revenue of C$161.14 million during the quarter, compared to analysts’ expectations of C$168.50 million. Andlauer Healthcare Group had a net margin of 10.02% and a return on equity of 13.82%. On average, equities analysts forecast that Andlauer Healthcare Group will post 1.6396243 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Ronald Martin Skelton sold 1,500 shares of Andlauer Healthcare Group stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of C$40.87, for a total transaction of C$61,309.95. Insiders own 1.43% of the company’s stock.

Andlauer Healthcare Group Company Profile

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.